SHANGHAI, China I March 17, 2025 I Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an Investigational New ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...

Arrowhead's ARO-C3 cut C3 levels by up to 89% and proteinuria by 41% in a Phase 1/2 trial. Additional results will be ...

The global liver fibrosis treatment market is poised for substantial growth, with revenue projections increasing from USD 17.51 billion in 2024 to USD 51.16 billion by 2033. This expansion represents ...

It will also test whether combining the conditional mutations of ORC1 and ORC2 will allow the liver cells to survive and endoreduplicate. If hepatocyte survival and endoreduplication is seen in these ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic fatty liver diseases (NAFLD) into more severe forms of liver disease by ...

LyGenesis, Inc., a clinical-stage biotechnology company developing cell therapies for organ regeneration, today announced that the Data and Safety Monitoring Board (DSMB) has completed its review of ...

Drug-induced liver injury (DILI) is a significant concern in clinical practice, arising from medications, herbs, and dietary supplements.

College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, P.R. China Key Laboratory of the Provincial Education Department of Heilongjiang for Common Animal Disease Prevention ...

This cover highlights the article Multimodal mechanisms of human centriole engagement and disengagement by Kei K. Ito, Shoji Hata, Daiju Kitagawa and colleagues. The cover image depicts the centriole ...